Quick Answer
Androgenetic alopecia is a genetic condition in which sensitivity to dihydrotestosterone (DHT) causes hair follicles to gradually shrink, producing thinner hair strands. Androgenetic alopecia treatment focuses on slowing this process and stimulating hair growth, with minoxidil and finasteride among the most clinically established options.
Finding an effective alopecia treatment can be difficult when medicines, scalp serums and shampoos all promise thicker hair. Androgenetic alopecia, also called male or female pattern hair thinning, gradually affects the hairline, crown or central parting.
Treatment decisions depend on how far thinning has progressed and which hair follicles remain responsive. Understanding how different medicines work can help you choose an appropriate treatment with a dermatologist.
How Does Androgenetic Alopecia Affect Hair Growth?
Androgenetic alopecia causes gradual hair thinning by making hair follicles smaller over time. This happens because certain hair follicles are genetically sensitive to a hormone called dihydrotestosterone (DHT). DHT affects sensitive hair follicles and gradually shortens their growth phase. A
This process is called follicular miniaturisation. It commonly affects the hairline and crown in men, while women usually notice widening of the central parting and reduced hair density.
As the condition progresses, affected follicles may produce very fine strands, making the scalp increasingly visible.

What Is the Best Treatment for Androgenetic Alopecia?
The most established androgenetic alopecia treatment options are topical minoxidil for men and women and oral finasteride for eligible men. These medicines target different aspects of androgenetic alopecia.
Medical management of genetic hair loss would depend on the degree of miniaturisation as well as noticing how the treatment works. Based on the clinical evidence below, you can review how the treatment worked on the people and how effective it was based on clinical evidence:
|
Treatment |
How It Works |
Clinical Evidence |
|
Topical minoxidil |
Promotes hair growth and helps maintain density |
Study Scope: 48-week trial involving 393 men. 5% vs 2%: 5% minoxidil yielded 45% greater hair growth than 2%. Proven Efficacy: Both 5% and 2% concentrations were significantly more effective than placebo. |
|
Oral finasteride |
Reduces DHT production in men |
Study Size: 2 clinical trials with 1,553 men (2-year duration) Key Result: Increased by 138 hairs vs. placebo Test Area: Per 1-inch target scalp area Dose Tested: Finasteride 1 mg daily |
|
Topical finasteride |
Reduces DHT activity, with some systemic absorption |
Study Size: Phase III trial with 458 men (24-week duration) Key Result: Increase of 20.2 hairs vs. increase of only 6.7 hairs for placebo in target scalp area Formulation: Tested topical Finasteride spray formulation |
|
Oral dutasteride |
Suppresses DHT through two enzyme pathways |
Study Size: 24-week clinical trial on 917 men Key Result: Outperformed finasteride 1 mg in both hair count and strand thickness Dose: Dutasteride 0.5 mg daily |
|
Oral spironolactone |
Reduces androgen-related effects in selected women |
Evidence: 2023 systematic review and meta-analysis (female patients) Response Rate: ~57% overall improvement rate |
|
Low-dose oral minoxidil |
Stimulates hair growth through systemic treatment |
Study Size: 2024 clinical trial with 90 men for 24-week duration Key Result: Oral 5 mg daily = Topical 5% twice daily (shows equivalent primary hair volume increase for both oral and topical) Dose: Oral minoxidil 5 mg daily |
|
PRP therapy |
Uses platelet-rich plasma injections to support follicle activity |
Study Size: 2024 meta-analysis of 14 clinical trials with 431 patients Key Result: +27.55 hairs/cm² average increase vs. normal condition Note: There is high variability in PRP preparation protocols and trial quality |
How Does Minoxidil Work for Androgenetic Alopecia?
Minoxidil is clinically proven to help improve hair density and slow progressive thinning in people with androgenetic alopecia. It helps affected hair follicles remain in the active growth phase (anagen) for longer, allowing them to produce thicker hair strands.
Minoxidil does not block dihydrotestosterone (DHT), instead, it supports hair growth in follicles that remain responsive to treatment. The most common forms available include:
Topical Minoxidil: Solutions and Foams
Topical minoxidil is an established androgenic alopecia treatment available as scalp solutions and foams, commonly in 2% and 5% concentrations. The appropriate strength and application frequency depend on the formulation, medical assessment and individual tolerance.
Clinical trials have demonstrated that topical minoxidil can improve hair density in both men and women with androgenetic alopecia. According to the American Academy of Dermatology, visible improvement may take 6–12 months, and continued use is necessary to maintain the results.
Temporary increased hair fall may occur during the first few weeks as follicles move into a new growth cycle. Other possible side effects include scalp irritation, itching and unwanted facial hair growth. Foam formulations may cause less irritation in some people.
Oral Minoxidil Tablets
Low-dose oral minoxidil is an off-label medicine for alopecia that dermatologists may prescribe when topical minoxidil is poorly tolerated or difficult to use consistently. Unlike topical solutions, oral minoxidil acts throughout the body and requires additional safety considerations.
A 2024 randomised clinical trial involving 90 men compared oral minoxidil 5 mg once daily with topical minoxidil 5% twice daily over 24 weeks. The researchers found that oral minoxidil was not significantly more effective than topical minoxidil for the study's main hair-density outcomes.
In the same trial, unwanted body or facial hair growth occurred in 49% of participants assigned oral minoxidil, compared with 25% in the topical group.
Oral minoxidil may also cause fluid retention, ankle swelling, dizziness, palpitations and changes in blood pressure. It should only be taken under medical supervision, particularly in patients with cardiovascular concerns.
Important: Minoxidil can improve hair density, but it does not permanently cure androgenetic alopecia. Stopping treatment generally causes the benefits to diminish over the following months.
Which Other Medicines Help Treat Androgenetic Alopecia?
The main prescription alopecia medicine options include finasteride, dutasteride and spironolactone.
These medicines work through different hormonal pathways and are prescribed according to the patient's condition:
Finasteride for Male-Pattern Hair Thinning
Finasteride is an oral alopecia tablet that blocks type II 5-alpha reductase, the enzyme responsible for converting testosterone into dihydrotestosterone (DHT) in men. This reduces DHT levels and helps preserve hair density in men with androgenetic alopecia.
Finasteride 1 mg daily is an established treatment for adult men. Improvements are generally assessed after 6–12 months of consistent use.
Possible side effects include reduced sexual desire, erectile difficulties, breast tenderness and mood changes. Finasteride is contraindicated during pregnancy because it may affect the development of a male fetus.
Dutasteride for Progressive Thinning
Dutasteride blocks both type I and type II 5-alpha reductase, resulting in greater DHT suppression than finasteride.
Clinical trials have shown improvements in hair density with dutasteride 0.5 mg, including greater hair-count improvements than finasteride 1 mg in some studies. Its approval for androgenetic alopecia varies by country, so treatment requires specialist assessment.
Potential side effects include sexual difficulties and breast tenderness. Dutasteride is also contraindicated during pregnancy.
Spironolactone for Female-Pattern Thinning
Spironolactone is an anti-androgen medicine for alopecia prescribed off-label for selected women with female-pattern thinning. It blocks androgen receptors and reduces the effects of hormones that contribute to hair follicle miniaturisation.
Dermatologists may consider spironolactone when standard topical treatment provides insufficient improvement. Its effectiveness varies, and clinical evidence is less extensive than that for established first-line treatments.
Possible side effects include irregular menstrual periods, dizziness, breast tenderness and elevated potassium levels. It should not be used during pregnancy, and patients may require kidney function and potassium monitoring.
Can Alopecia Drops, Lotions and Serums Help?
Alopecia drops and scalp serums can help when they contain clinically supported active medicines, particularly minoxidil.
Topical products, such as solutions, foams, and liposomal serums, can help based on how deeply active ingredients can penetrate the scalp and work on the hair follicles to prevent local DHT production or stimulate microcirculation:
Minoxidil-Based Alopecia Lotion
An alopecia lotion containing minoxidil delivers the medicine directly to the scalp. Consistent application may help maintain hair density and improve thickness in responsive areas.
Some formulations contain alcohol or propylene glycol, which may irritate sensitive scalps. Foam formulations can be better tolerated by certain patients.
Topical Finasteride Solutions
Topical finasteride has demonstrated benefits in clinical trials involving men with androgenetic alopecia.
A phase III trial involving 458 randomised participants found improved hair counts with a specific topical finasteride spray compared with placebo.
Topical application may reduce systemic exposure compared with oral treatment, but absorption still occurs. Safety and regulatory status depend on the formulation. It should only be used with appropriate medical guidance.
Cosmetic Hair Growth Serums
Serums containing caffeine, peptides or herbal extracts are marketed for hair thinning. However, their clinical evidence remains less consistent than that supporting minoxidil and finasteride.
These formulations should not replace established alopecia medicine when treatment is medically indicated.
Do Shampoos Help With Androgenetic Alopecia?
Ketoconazole shampoo is sometimes considered when androgenetic alopecia occurs alongside dandruff or seborrhoeic dermatitis.
A 2020 systematic review included five human studies involving 318 participants and reported encouraging findings for ketoconazole. However, the authors concluded that stronger clinical trials were needed before establishing its effectiveness for androgenetic alopecia.
Shampoos containing biotin, caffeine or other cosmetic ingredients may improve hair appearance, but they do not have the same established clinical role as minoxidil or finasteride.
How Long Does Androgenetic Alopecia Treatment Take to Work?
Most alopecia treatments take several months before visible changes appear. Treatment response depends on the medicine, severity of thinning and individual follicle activity.
Hair follicle stem cells move through biological phases (Anagen, Catagen, Telogen) and each treatment can can take the following time period to show any visible changes:
|
Treatment |
Typical Assessment Period |
|
Topical minoxidil |
6–12 months |
|
Oral finasteride |
6–12 months |
|
Low-dose oral minoxidil |
Around 3–6 months initially |
|
Spironolactone |
Around 6–12 months |

Can Alopecia Come Back After Stopping Medication ?
Yes, androgenetic alopecia can continue progressing after stopping medication, and improvements gained during treatment may gradually disappear. Medicines such as minoxidil and finasteride help control genetic hair thinning, but their effects generally last only while treatment continues.
Note: Stopping medication does not necessarily cause permanent damage to hair follicles. However, the underlying condition remains active, so thinning may become noticeable again.
Traya's Approach to Androgenetic Alopecia Treatment
Androgenetic alopecia requires long-term care because genetic sensitivity to DHT gradually causes hair follicles to shrink. However, nutritional deficiencies, hormonal conditions and scalp concerns may also contribute to hair fall. Identifying these additional factors helps determine which concerns need separate attention alongside genetic hair thinning.
To identify the root causes of your hair fall, take the Traya Free Hair Test. Traya's Hair Test helps assess hair fall patterns, lifestyle habits, nutritional health and possible contributing factors such as stress, poor sleep and hormonal changes.
Traya follows a personalised 3-Science approach combining Hair Science, Ayurveda and Nutrition. Based on the assessment, Traya develops a personalised plan that may include nutritional support, scalp care and appropriate hair treatments. The aim is to address identified contributing factors while supporting long-term hair health. Genetic sensitivity itself cannot be eliminated, so managing androgenetic alopecia may still require ongoing medical treatment.
Frequently Asked Questions
Can Minoxidil Permanently Cure Androgenetic Alopecia?
No. Minoxidil can improve hair density and slow thinning, but its benefits generally depend on continued use. Androgenetic alopecia cannot currently be permanently cured with medication.
Can Alopecia Drops Restore Thinning Hair?
Minoxidil-based scalp solutions can improve hair density in some patients, especially where follicles remain responsive. Cosmetic drops without established active medicines have less reliable evidence.
Can Androgenetic Alopecia Be Treated Naturally?
No natural remedy has demonstrated the same consistent clinical effectiveness as established medicines. Nutritional support can help when a deficiency is present, but it does not directly reverse genetic follicular miniaturisation.
References:
- Parikh AK, Tan IJ, Wolfe SM, et al. (2022). Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, and Monitoring. Journal of Clinical and Aesthetic Dermatology.
- Feinstein RP. (2023). Androgenetic Alopecia Treatment & Management. Medscape Reference.
- Penha, M. A., Miot, H. A., Kasprzak, M., & Ramos, P. M. (2024). Oral minoxidil vs topical minoxidil for male androgenetic alopecia: A randomized clinical trial. JAMA Dermatology, 160(6), 600–605. DOI: https://doi.org/10.1001/jamadermatol.2024.0284
- Cleveland Clinic. (2023). Male Pattern Baldness (Androgenic Alopecia). Cleveland Clinic Health Library.
- Ly NY, Burns KH, Mesinkovska NA. (2023). Medical and Procedural Treatment of Androgenetic Alopecia. Journal of the American Academy of Dermatology. DOI: 10.1016/j.jaad.2023.03.048
- Miot HA, Lunas AB, Castro CC. (2023). Female-Pattern Hair Loss: Therapeutic Update. Anais Brasileiros de Dermatologia. DOI: 10.1016/j.abd.2022.09.006
- Rossi A, Anzengruber F, Soares DM, et al. (2014). Androgenetic Alopecia: An Update on Diagnosis and Treatment. Giornale Italiano di Dermatologia e Venereologia.
- Kelly Y, Blanco A, Tosti A. (2016). Androgenetic Alopecia: An Update of Treatment Options. Drugs. DOI: 10.1007/s40265-016-0629-5
- York K, Meah N, Bhoyrul B, Sinclair R. (2020). A Review of the Treatment of Male Pattern Hair Loss. Expert Opinion on Pharmacotherapy. DOI: 10.1080/14656566.2020.1721463
- Practical Dermatology. (2009). Ethics and Dermatology: Finding Harmony in Daily Practice. Practical Dermatology.
- Adil A, Godwin M. (2017). The Effectiveness of Treatments for Androgenetic Alopecia: A Systematic Review and Meta-Analysis. Journal of the American Academy of Dermatology. DOI: 10.1016/j.jaad.2017.02.054
- Van Neste D, Fuh V, Sanchez-Pedreno P, et al. (2000). Finasteride Increases Anagen Hair in Men With Androgenetic Alopecia. British Journal of Dermatology. DOI: 10.1046/j.1365-2133.2000.03780.x
- Fischer TW, Burmeister G, Schmidt HW, Elsner P. (2004). Melatonin Increases Anagen Hair Rate in Women With Androgenetic Alopecia or Diffuse Alopecia: Results of a Pilot Randomized Controlled Trial. British Journal of Dermatology. DOI: 10.1111/j.1365-2133.2004.05685.x
- Lolli F, Pallotti F, Rossi A, et al. (2017). Androgenetic Alopecia: A Review. Endocrine. DOI: 10.1007/s12020-017-1280-y
- Olsen, E. A., Dunlap, F. E., Funicella, T., Koperski, J. A., Swinehart, J. M., Tschen, E. H., & Trancik, R. J. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 47(3), 377–385. DOI: https://doi.org/10.1067/mjd.2002.124088
- Kieling, L., Konzen, A. T., Zanella, R. K., & Valente, D. S. (2024). Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials. Anais Brasileiros de Dermatologia, 99(6), 847–862. DOI: https://doi.org/10.1016/j.abd.2024.01.002
- Penha, M. A., Miot, H. A., Kasprzak, M., & Ramos, P. M. (2024). Oral minoxidil vs topical minoxidil for male androgenetic alopecia: A randomized clinical trial. JAMA Dermatology, 160(6), 600–605. DOI: https://doi.org/10.1001/jamadermatol.2024.0284
- Aleissa, M. (2023). The efficacy and safety of oral spironolactone in the treatment of female pattern hair loss: A systematic review and meta-analysis. Cureus, 15(8), e43559. DOI: https://doi.org/10.7759/cureus.43559
- Gubelin Harcha, W., Barboza Martínez, J., Tsai, T.-F., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489–498.e3. DOI: https://doi.org/10.1016/j.jaad.2013.10.049
- Piraccini, B. M., Blume-Peytavi, U., Scarci, F., Jansat, J. M., Falqués, M., Otero, R., Tamarit, M. L., Galván, J., Tebbs, V., & Massana, E. (2022). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: A phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology, 36(2), 286–294. DOI: https://doi.org/10.1111/jdv.17738
- Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., Shapiro, J., Binkowitz, B., & Gormley, G. J. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 39(4), 578–589. DOI: https://doi.org/10.1016/S0190-9622(98)70007-6
Read More Blogs
Androgenetic Alopecia: Complete Hair Loss Guide
Quick Answer Androgenetic alopecia is a common form of patterned hair loss caused b...
Can a Receding Hairline Grow Back?
Quick Answer A receding hairline may grow back if the hair follicles around your foreh...
Olive Oil for Hair Fall: Does It Really Help?
Quick Answer Olive oil can help reduce hair fall caused by dryness and breakage by sof...
How to Reverse Male Pattern Baldness Naturally: Treatments & Hair Regrowth Tips
Quick Answer Natural care can help reduce hair damage and support healthy hair growth,...





























